DETAILS, FICTION AND SQUALENE

Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are the most maturely developed TPD strategies. In this particular overview, we target both equally preclinical experiments and scientific trials to provide a comprehensive summary of the safety and scientific usefulness of PROTACs and MGDs in hematologic malignancies over